Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases
Background: Polycystic ovary syndrome (PCOS) is a serious threat for reproductive-aged women. Metformin has been used for the treatment of PCOS. However, its molecular mechanism in decidualization process of PCOS has not been well featured. Methods: RT-qPCR analysis was used to detect expression pat...
Main Authors: | Fang Xiong, Juxia Xiao, Yinyang Bai, Yun Zhang, Qiuping Li, Xu Lishuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218360591 |
Similar Items
-
Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome
by: Meenakumari K.J., et al.
Published: (2004-01-01) -
Metformin and kidney protection; a letter to editor on recent findings
by: Sahar Koushki, et al.
Published: (2019-01-01) -
NLRP7 contributes to in vitro decidualization of endometrial stromal cells
by: Jyun-Yuan Huang, et al.
Published: (2017-08-01) -
Endometrial stromal beta-catenin is required for steroid-dependent mesenchymal-epithelial cross talk and decidualization
by: Zhang Ling, et al.
Published: (2012-09-01) -
Metformin and Colorectal Cancer
by: Takuma Higurashi, et al.
Published: (2018-10-01)